Author: gao song; meng qun cheng; xian wen wei
Title: Advance of Novel Coronavirus Registration Clinical Trial Document date: 2020_3_20
ID: fk2wc715_25
Snippet: Among them, 32.26% of Cell therapy is mesenchymal stem cells, 9.68% of Cell therapy is Cord Blood Mononuclear Cell, 3.23% of Cell therapy is Menstrual Blood-derived Stem Cells, and 3.23% of Cell therapy is Natural Killer Cell. Figure 3ã€4 and Table 4 for a summary of the high research frequency drugs for CMT and BI......
Document: Among them, 32.26% of Cell therapy is mesenchymal stem cells, 9.68% of Cell therapy is Cord Blood Mononuclear Cell, 3.23% of Cell therapy is Menstrual Blood-derived Stem Cells, and 3.23% of Cell therapy is Natural Killer Cell. Figure 3ã€4 and Table 4 for a summary of the high research frequency drugs for CMT and BI.
Search related documents:
Co phrase search for related documents- Cell therapy and mesenchymal stem cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- Cell therapy and research frequency: 1
- Cell therapy and stem cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- high research frequency and research frequency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- mesenchymal stem cell and stem cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date